Companies: 10,795·Total market cap: $144.5T

United Therapeutics Corporation

United Therapeutics Corporation

UTHRNASDAQHealthcare● Active

$549.87

+$2.18(+0.40%)

Market Cap$23.3B

P/E Ratio—

52W High$609.35

52W Low$272.12

Avg Volume546K

Open$547.10

Beta0.57

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

United Therapeutics Corporation（UTHR）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · UTHR · 截至 Jun 8, 2026

关键指标

EPS (TTM)$29.27Earnings history

PE Ratio (TTM)18.8×PE Ratio deep dive

Revenue (TTM)$3.2BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding44.3MShares outstanding history

Next EarningsJul 29, 2026Est.Earnings history

探索 United Therapeutics Corporation 数据

分析师预测$637 · Buy

股息不分红

营收$3.2B+10.61%

盈利EPS $30.13+13.96%

市盈率18.8×

财务快照

FY 2025Revenue$3.18B▲ +10.61% YoY

202320242025

FY 2025Net Income$1.33B▲ +11.68% YoY

202320242025

FY 2025EPS$30.13▲ +13.96% YoY

202320242025

TTM:Revenue: $3.17BNet Income: $1.29BEPS: $29.27View income statement →

分析师评级与目标价

Buy30 位分析师

Strong Buy

0

Buy

17

Hold

12

Sell

1

Strong Sell

0

12-Month Price Target

$516.00Low

$549.87Current

$636.83Avg Target上涨空间 15.81%

$735.00High

合计: 30 · 买入占比: 56.7%

根据过去 3 个月内 30 位华尔街分析师，UTHR 共识评级为 Buy，12 个月平均目标价 $636.83 （较现价 $549.87 上涨空间 15.81%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

United Therapeutics Corporation

$549.87+0.40%$23.3B #2

$195.34-0.57%$28.8B #3

Quest Diagnostics Incorporated

$200.29+2.13%$22.2B #4

$25.15+1.70%$15.4B #5

$162.32-3.42%$24.6B #6

Incyte Corporation

$102.38+1.13%$20.5B

股票表现

1D+0.40%

1W+1.17%

1M-2.67%

3M+15.00%

YTD+12.85%

1Y+67.44%

5Y+222.56%

关于 United Therapeutics Corporation

CEOMartine A. Rothblatt

IPO DateJun 17, 1999

Employees1,305

CountryUS

Websiteunither.com

United Therapeutics Corporation a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening …

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

United Therapeutics Corporation（UTHR）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 17, 1999 在 NASDAQ 上市。截至最近交易日，UTHR 股价为 $549.87，市值约为 $23.3B。过去12个月累计回报 +67.44%，年初至今回报 +12.85%。

根据 30 位华尔街分析师，United Therapeutics Corporation 股票共识评级为Buy，12个月平均目标价为 $636.83。2025 财年 United Therapeutics Corporation 营收 $3.2B，净利润 $1.3B。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，United Therapeutics Corporation（UTHR）股价为 $549.87，在 NASDAQ 上市，52周区间为 $272.12 – $609.35。

UTHR 最新股价UTHR quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议